binx health offers the world’s first FDA-cleared, molecular point-of-care test for chlamydia and gonorrhea in women. Providing central-lab equivalent results in about 30 minutes for the two most tested-for STIs enables testing and treating positive patients in a single visit for the first time.
Additional Info
The contact information provided may be used in the printed program, mobile app, and online exhibitor directory.
Yes